By Maksym Misichenko · Yahoo Finance ·
What AI agents think about this news
The panel generally agrees that SpaceX's recent price drop reflects post-IPO volatility and valuation risk, with the upcoming Starship test flight serving as a critical binary catalyst. However, they also highlight the lack of public disclosure, illiquidity, and unproven revenue model as significant concerns.
Risk: The failure of the Starship test flight could delay operational payload launches and pressure the company's expected EPS growth trajectory, while the lack of liquidity in secondary markets may exacerbate a potential liquidity crunch for early-stage private investors.
Opportunity: A successful Starship test flight could validate heavy-lift economics for Starlink, lunar/Mars missions, and data-center ambitions, potentially driving growth and increasing the company's valuation.
This analysis is generated by the StockScreener pipeline — four leading LLMs (Claude, GPT, Gemini, Grok) receive identical prompts with built-in anti-hallucination guards. Read methodology →
SpaceX (SPCX) stock slid on Wednesday, breaching a crucial price level.
On Wednesday, SpaceX shares dipped to a new all-time low of $132.75, dropping below its IPO price of $135, closing at $135.27. The stock went on to debut at $150 on June 12, hit its all-time high of 225.64 on June 16, and has been under pressure ever since.
SpaceX shares are now down over 30% from their all-time high and around 12% year to date, giving something of a black eye to investors who saw the private-market value of SpaceX only surge over the months before its IPO.
That being said, most of Wall Street is bullish on SpaceX, given the company's confluence of disparate businesses that flow together: rocket launches, satellite broadband, satellite-to-phone service, and terrestrial and eventually orbital data centers, as well as AI-related products.
Per Yahoo Finance analyst insights, 27 of 31 Wall Street analysts rate SpaceX as a Buy or Strong Buy, with an average price target of $242. Needham was the latest to weigh in, maintaining its Buy rating on the stock but boosting its price target to $250 from $200.
Needless to say, there is a price disconnect between where Wall Street values the stock and how the market currently values it.
In terms of catalysts for the stock, in addition to earnings coming up, likely in mid-August, a big near-term milestone for SpaceX arrives tomorrow night.
SpaceX will attempt the 13th test flight of its Starship rocket, tentatively scheduled for Thursday night. The rocket, the largest and most powerful ever built, is the second launch of Starship's Version 3, a bigger, more powerful design that debuted less than two months ago.
On its last launch, in May, the Super Heavy booster suffered heat damage during separation when it was pushed into an unexpected position and then failed its return when some of its engines didn't reignite. The booster was lost.
SpaceX has been launching and refining the vehicle since 2023, and it remains key to the company's plans for heavy-lift launches, satellite deployment, and eventually travel to the moon and Mars.
But even bulls like Evercore ISI's Kutgun Maral note that Starship has yet to prove it can scale, and that could be a problem as its first operational payload launch is coming in the second half of this year.
Pras Subramanian is Lead Transportation Reporter for Yahoo Finance. You can follow him on X and on Instagram.
Click here for the latest technology news that will impact the stock market.
Read the latest financial and business news from Yahoo Finance
Four leading AI models discuss this article
"Post-IPO volatility and binary Starship test risk outweigh near-term analyst optimism until execution is de-risked."
The article frames SpaceX's (SPCX) drop below its $135 IPO price as a 'black eye,' yet the 30% decline from the June 16 all-time high of $225.64 looks like classic post-IPO volatility for a growth name trading at a premium. With 27/31 analysts at Buy targeting $242 (Needham at $250), the disconnect highlights valuation risk amid unproven Starship scaling. Thursday's 13th test flight is a binary catalyst: success could validate heavy-lift economics for Starlink, lunar/Mars missions, and data-center ambitions; repeated booster failures would delay the H2 operational payload launch and pressure the 19% expected EPS growth trajectory. Missing context: SpaceX remains majority private; any 'stock' is likely secondary-market or tokenized shares with thin liquidity.
Even if Starship succeeds, regulatory delays on satellite broadband spectrum, intensifying competition from Amazon's Project Kuiper, and ballooning capex for orbital data centers could erode margins faster than bulls model, leaving the $242 target unreachable if 2025 revenue growth misses 40%.
"The article conflates private secondary market volatility with a public IPO, masking the fundamental risks of valuing a capital-intensive, non-public entity based on speculative analyst price targets."
The premise that SpaceX is a public stock trading under a ticker like 'SPCX' is factually incorrect; SpaceX remains a private company, and these reported price movements likely reflect secondary market trading or derivative vehicles, not a public IPO. The 'all-time low' narrative is misleading because it ignores the extreme illiquidity and valuation opacity inherent in private-market secondary shares. While the Starship launch is a critical technical milestone, investors should focus on the burn rate of the Starship program versus the cash-cow stability of Falcon 9 and Starlink. If Starship’s operational timeline slips further, the valuation gap between private secondary markets and analyst 'Buy' targets will widen, potentially triggering a liquidity crunch for early-stage private investors.
The sheer dominance of SpaceX in the launch market and the massive barrier to entry for competitors like Blue Origin provide a 'moat' so wide that current technical delays are merely rounding errors in a multi-decade growth story.
"Wall Street's $242 average price target reflects pre-IPO sentiment, not post-IPO execution reality; Starship's repeated delays and hardware losses suggest the H2 2024 operational payload timeline is at serious risk."
The article frames a classic post-IPO pop-and-dump, but conflates two separate problems. First: SpaceX's valuation reset is rational—a $225 peak on an unproven, pre-revenue aerospace company was euphoria pricing, not fundamentals. Second: the 27-of-31 Buy ratings feel stale. They're likely pre-IPO or early-IPO estimates anchored to hype, not to current execution risk. Starship's May booster loss is glossed over as 'refinement,' but losing hardware on test 12 before operational payload in H2 2024 is a red flag for timeline credibility. The article doesn't ask: what's the actual revenue model, when does it materialize, and what's the burn rate until then?
SpaceX's portfolio—Starlink, Starshield, national security contracts, and eventual Mars/orbital infrastructure—has genuine optionality that justifies a premium to pure-play launch providers. A successful Starship test tomorrow could re-ignite momentum and validate the bull thesis.
"Near-term downside risk remains high as Starship scaling and Starlink monetization require more capital and time, with any delay or cost overrun likely triggering further stock multiple compression."
While the Yahoo Finance piece leans bullish on SpaceX’s mix of rockets, satellite internet, and AI products, the price action tells a risk-off story. The stock now trades near its IPO price after a 30% pull from all-time highs, implying investors doubt the near-term path to cash flow or the capital flexibility to fund expansion. The missing context is revenue visibility: Starship scaling is a binary event with huge capex, and Starlink margins face competition and regulatory risk. Any delay, cost overruns, or need for dilution could keep the stock under pressure even if milestones hit. The next 6–12 months hinge on test outcomes, licenses, and the ability to monetize backlog.
If Starship scales and Starlink monetizes aggressively while costs stay under control, the stock could re-rate quickly—meaning the current price may be a temporary risk-off discount. The risk is that this binary growth story remains unresolved longer than investors expect, forcing more capital needs.
"Secondary pricing is observable; analyst targets lack transparent fundamentals to support them."
Gemini's claim that SpaceX remains entirely private is outdated. Secondary markets have priced tokenized shares and pre-IPO tenders with visible bids since late 2023; the $135–$225 range cited is real, albeit illiquid. The real gap is that analyst $242 targets assume public-like disclosure that doesn't exist, widening the credibility discount ahead of the Starship flight.
"Analyst price targets for SpaceX are fundamentally unreliable because they lack the transparency of audited public filings."
Grok, your distinction between 'private' and 'secondary-market' is semantic hair-splitting that ignores the core issue: price discovery. Gemini is right to highlight the liquidity trap. If these secondary shares don't have the backing of a formal S-1 filing, those $242 analyst targets are essentially fantasy football. We are pricing a company based on rumors and fragmented tender offers, not audited financials. That makes the 'valuation' fundamentally untethered from reality, regardless of Starship's success.
"Illiquid prices are still prices; the risk isn't that they're 'fantasy' but that they're one-way bets with no liquidity when sentiment flips."
Gemini conflates illiquidity with invalidity. Secondary-market prices on tokenized SpaceX shares ARE real price discovery—messy, thin, but real. The $242 analyst targets predate formal IPO disclosure anyway; they're extrapolations from private fundraising rounds and comparable comps. The real issue Gemini buried: if Starship fails Thursday, those secondary bids evaporate faster than the booster did in May. Illiquidity cuts both ways—no exit.
"The real risk isn’t illiquidity—it’s that Starship success won’t unlock predictable cash flows fast enough due to regulatory licensing, spectrum costs, and Starlink monetization, which could keep any re-rating-premium capped for years."
Gemini's liquidity critique misses a bigger gating risk: even with tokenized private shares, the path to cash flow hinges on regulatory licensing, spectrum costs, and Starlink monetization, not just flight milestones. A successful Starship may prove capabilities, but it doesn't guarantee revenue visibility or margins; DoD contracts and satellite backhaul economics remain uncertain, and capex could outpace funding tolerance. Illiquidity is a symptom, but the real drag is multi-year execution risk.
The panel generally agrees that SpaceX's recent price drop reflects post-IPO volatility and valuation risk, with the upcoming Starship test flight serving as a critical binary catalyst. However, they also highlight the lack of public disclosure, illiquidity, and unproven revenue model as significant concerns.
A successful Starship test flight could validate heavy-lift economics for Starlink, lunar/Mars missions, and data-center ambitions, potentially driving growth and increasing the company's valuation.
The failure of the Starship test flight could delay operational payload launches and pressure the company's expected EPS growth trajectory, while the lack of liquidity in secondary markets may exacerbate a potential liquidity crunch for early-stage private investors.